Vaccines are here to help protect against serious illness from COVID-19. Due to limited  supply the Health Department will be prioritizing vaccinating our most vulnerable residents, Phase 1B: Adults ages 75 and older. It may take a couple of weeks before we are able to register other eligible populations in Phases 1B & 1C.

Maryland COVID-19 Vaccine Priority Groups

Maryland will distribute the vaccines to five different priority groups based on relative risk of exposure or developing serious illness.

MARYLAND IS IN PHASE 1C:

  • All licensed, registered and certified health care providers
  • Front line hospital staff
  • Nursing home residents and staff
  • Individuals with intellectual and developmental disabilities
  • Assisted living, independent living, behavioral health and developmentally disabled group homes, and other congregate facilities
  • Law enforcement and firefighters, EMS
  • Education staff, including K-12 teachers, support staff and daycare providers
  • Correctional health care staff and officers
  • Public safety workers not covered in Phase 1A
  • Health care workers not covered in Phase 1A, including but not limited to lab services, public health, vaccine manufacturing and other health care professions
  • Front line judiciary staff
  • Continuity of government
  • Food/agriculture production, critical manufacturing, U.S. Postal Service, public mass transit, grocery store employees
  • Veterinarians and support staff
  • Clergy and other essential support for houses of worship
  • Adults age 65 and older
  • Individuals who are currently receiving hospital-based treatment, including in hospital outpatient centers, AND diagnosed with at least one of the following conditions:
    • Cancer patients who are currently in active treatment
    • End stage renal disease patients requiring hemodialysis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Solid organ transplant recipients
    • Sickle cell disease patients
    • Diabetic patients (Type 1 and Type 2)
  • Individuals who are diagnosed with these medical conditions but are not currently receiving hospital-based treatment, including in hospital outpatient centers, will be eligible to receive the vaccine in Maryland’s Phase 2 COVID-19 vaccine distribution.

If you are included in one of the groups listed above, you are currently eligible to receive a COVID-19 vaccination.

Phase 1C

TIMELINE: ONGOING

Phase 1A

  • Health care workers
  • Residents and staff of nursing homes
  • First responders, public safety, corrections

Phase 1B

  • Assisted living, other congregate settings
  • Adults ages 75 and older
  • Education and continuity of government

 

Phase 1C*

  • Adults ages 65-74
  • Essential workers in lab services, agriculture, manufacturing, postal service, etc.
  • Immunocompromised receiving hospital-based treatment

*Maryland is currently in this stage.

 

Phase 2

  • Adults 16-64 at increased risk of severe COVID-19 illness due to comorbidities
  • Essential workers in critical utilities, transportation, food service, etc.

 

Phase 3

  • General population, including healthy adults ages 16-64

 

Vaccine prioritization may be subject to change. The state has adopted a rolling vaccine allocation model, meaning it may not wait for every member of a particular group to get vaccinated before moving ahead; individuals will still have the opportunity to be vaccinated in subsequent phases.

Registration Process

To assist you in the online vaccine registration process, the Health Department has created an eligibility prescreening form to gather contact information that will be used to communicate vaccination clinic registration information. Please take a few moments to familiarize yourself with the registration process.

To see if you are part of the current priority group visit:
To access the eligibility screening form:
For those without Internet access, please call 410-996-1005 for assistance.

We will begin collecting information on individuals eligible in Phases 2 and 3 in the near future.

What are the Vaccines?

Vaccines Status Dosing Efficacy Potential Side
Effects
Pfizer Vaccine has been authorized for emergency use Two doses, delivered three weeks apart 95% effective at preventing serious illness Injection-site pain, fatigue, headaches, chills
Moderna Vaccine has been authorized for emergency use Two doses, delivered four weeks apart 94.1% effective at preventing serious illness Injection-site pain, fatigue, muscle aches, joint pain, headaches, chills
AstraZeneca Vaccine trials are ongoing Two doses, delivered four weeks apart. NOTE: A half-dose may be recommended for the first dose. Fever, muscle ache, headache, injection-site pain

Why Should You Get the Vaccine?

Protective
It helps to protect you and those around you from COVID-19.

Promising results
Early clinical trials show the vaccines are highly effective in preventing serious illness.

Pandemic-ending
These vaccines are the path forward to ending the COVID-19 pandemic.

Minimal side effects
Most of the participants in clinical trials had minimal side effects. The most common were soreness at injection site, fever, or body aches.